VisionCare Ophthalmic Technologies

company

About

VOT develops visual prosthetic devices to improve vision in patients with end-stage age-related macular degeneration.

  • Saratoga,California,United States
  • 1 - 10

Details

Last Funding Type
Series D
Last Funding Money Raised
$20M
Industries
Health Care,Medical,Medical Device
Founded date
Jan 1, 1997
Number Of Employee
1 - 10
Operating Status
Active

VisionCare Ophthalmic Technologies, Inc., a Saratoga, CA-based developer of advanced visual prosthetic devices designed to improve vision in patients with end-stage age-related macular degeneration (AMD).

VisionCare Ophthalmic Technologies (VisionCare) is a privately held specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders.

Our lead product, the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), is the first FDA-approved implantable medical device demonstrated to improve vision and quality of life in individuals with the most advanced, irreversible form of age-related macular degeneration (AMD) – End-Stage AMD. End-Stage AMD is the leading cause of blindness in older Americans.

The telescope implant is integral to the CentraSight™ treatment program which has been developed to help patients follow the necessary steps for proper diagnosis, surgical evaluation, and postoperative care.

Our goal is to help patients reconnect to the things in life they love to see and do. To help achieve this, we will establish a high level of collaboration with our healthcare provider customers through a broad range of direct support programs and services.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
8
$95.20M
VisionCare Ophthalmic Technologies has raised a total of $95.20M in funding over 2 rounds. Their latest funding was raised on Dec 5, 2014 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 5, 2014 Series Unknown 1 Detail
Sep 17, 2013 Debt Financing $15M 1 Detail
Jan 23, 2012 Series E $4M Detail
Jan 10, 2011 Series E $31M 6 Saints Capital Detail
Jan 4, 2005 Series D $20M 4 Boston Scientific Detail

Investors

Number of Lead Investors
Number of Investors
2
11
VisionCare Ophthalmic Technologies is funded by 11 investors. Boston Scientific and Saints Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Boston Scientific Yes Series D
Saints Capital Series Unknown
Life Sciences Alternative Funding Debt Financing
BSI SA Series E
Giza Venture Capital Series E
ONSET Ventures Series E
Pitango VC Series E
Three Arch Partners Series E
Infinity Venture Capital Series C
Clal Industries Series A

Employee Profiles

Number of Employee Profiles
13
VisionCare Ophthalmic Technologies has 13 current employee profiles, including Board member David Israeli
Board member
Board member
Board member
Board member
Board member